Home
About
Overview
Sharing Data
ORCID
Help
History (20)
A new direction for titin pulling.
Correlates of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice.
[Automated Detection of Radiopaque Markers in Chest and Abdomen Radiography].
Successful Left Phrenic Nerve Block for Intractable Hiccups in a Patient With LVAD-Induced Diaphragmatic Irritation.
Cracked actin filaments as mechanosensitive receptors.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Koya, Richard
One or more keywords matched the following items that are connected to
Koya, Richard
Item Type
Name
Concept
Antigens, Neoplasm
Academic Article
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
Academic Article
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
Academic Article
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Academic Article
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
Academic Article
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
Academic Article
Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.
Academic Article
Immune rejection in a humanized model of murine prostate cancer.
Academic Article
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
Academic Article
Immunosensitization with a Bcl-2 small molecule inhibitor.
Academic Article
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Search Criteria
Antigens Neoplasm